Clinical Trial

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 18, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-19
Trial Details
NCT Number NCT07150845
Lead Sponsor Evommune, Inc.
Conditions Atoptic Dermatitis
Enrollment 120 participants
Start Date 2025-08-26
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-18